The United States District Court for the District of Delaware has passed its judgment in favor of Gevo, stating that it does not literally infringe as per its patent claims regulation.
Earlier in 2011, Butamax, a joint venture between BP and DuPont, had sued Gevo claiming that the latter had misused technology for genetically engineered microorganisms used to produce biofuels.
The company was accused of infringing Butamax’s two patents numbered 7,851,188 (‘188 Patent) and 7,993,889 (‘889 Patent).
Gevo executive vice president and general counsel Brett Lund applauded the final judgment saying that it would now allow the firm to operate freely.
"We feel vindicated that Butamax itself admitted that Gevo does not infringe when the Court’s interpretation of the patent claims is applied," noted Lund.
